Japan Emergency Approval System
2023 Volume 13 Issue 1 Pages 39-46
Details
2023 Volume 13 Issue 1 Pages 39-46
Since the outbreak of the COVID-19, emergency pharmaceutical review systems have been utilized in countries around the world for the early application of therapeutic drugs and vaccines. In Japan as well, multiple therapeutic drugs and vaccines have been rapidly approved by utilizing the special approval system, but in order to address the issue that it cannot be applied to drugs developed in Japan, May 20, 2022, an emergency approval system was created due to the revision of the Pharmaceuticals and Medical Devices Act. In the future, it will be important to utilize this system in emergencies and quickly commercialize medicines.
